HEC Placebo Gel

DRUG9 trials

Sponsors

Biosyn, Starpharma Pty Ltd, CONRAD

Conditions

18-30 Years of AgeContraceptionHIVHIV InfectionsHIV NegativeHIV PreventionHealthyHigh Risk MSM

Phase 1

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

BiosynHIV Infections

Start: 2005-06-30Target: 6Updated: 2005-10-25

Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Enhanced MRI Techniques to Increase Resolution

Target: 6Updated: 2005-12-02

Safety and Acceptability of SPL7013 Gel (VivaGel™) in Sexually Active Women

CompletedNCT00442910

Starpharma Pty LtdHealthy

Start: 2007-07-31End: 2009-12-31Updated: 2010-06-24

Rectal Safety and Acceptability Study of Tenofovir 1% Gel

CompletedNCT01232803

CONRADRectal Microbicides

Start: 2010-10-31End: 2011-07-31Updated: 2021-06-28

Microbicide Safety and Acceptability in Young Men

CompletedNCT01283360

CONRAD18-30 Years of Age, High Risk MSM, HIV Negative

Start: 2010-10-31End: 2013-05-31Updated: 2015-05-28

A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04

CompletedNCT01989663

Start: 2013-11-30End: 2015-01-31Updated: 2016-07-27

Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females

WithdrawnNCT02245945

CONRADHIV Prevention

Updated: 2015-05-01

Development of Adherence Biomarkers for Multiple Microbicide and Multipurpose Prevention Technology (MPT) Dosage Forms

CompletedNCT02569697

Start: 2015-10-31End: 2016-05-31Updated: 2016-09-02

Unknown Phase

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

CompletedNCT02602366

CONRADContraception, HIV

Start: 2016-06-06End: 2017-09-30Updated: 2018-05-18

Related Papers

Mucosal tenofovir 1% gel stimulates cell proliferation and type I/III interferon pathways.

2026-03-23

Project Gel a Randomized Rectal Microbicide Safety and Acceptability Study in Young Men and Transgender Women

PLoS ONE2016-06-3015 citations

A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007).

2013-04-0381 citations